A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
This report contains market size and forecasts of Prokinetic Drug in global, including the following market information:
Global Prokinetic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prokinetic Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prokinetic Drug companies in 2021 (%)
The global Prokinetic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metoclopramide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prokinetic Drug include Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals and Hanmi Pharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prokinetic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prokinetic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, by Type, 2021 (%)
Metoclopramide
Domperidone
Cisapride
Others
Global Prokinetic Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, by Application, 2021 (%)
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Global Prokinetic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prokinetic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prokinetic Drug revenues share in global market, 2021 (%)
Key companies Prokinetic Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prokinetic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm